Name: Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery
Start: 2025-11-15T08:25:00-05:00
End: 2025-11-15T12:30:00-05:00

June 2025
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes

June 20, 2025 @ 8:00 AM - 5:00 PM

CME 1.50 Credits Webcast Time to Complete: 90 minutes Released: September 5, 2024 Expires: September 5, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM Start Activity Program Description This webcast provides an update on the MGD-DED. Eyelid inflammation, microbial growth, associated skin disorders, and potentially severe corneal complications make MGD a complex multifactorial disorder. MGD is a…
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | CNE 1.50 Credits Webcast Time to Complete: 90 minutes Released: August 15, 2024 Expires: August 15, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM 1.50 / ANCC Contact Hours Start Activity Program Description This webcast provides an update on the blood-based markers (BBMs) improve randomized clinical trials (RCTs) design and conduct of Alzheimer’s disease. It…
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | CNE 1.50 Credits Webcast Time to Complete: 90 minutes Released: May 15, 2024 Expires: May 15, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM 1.50 / ANCC Contact Hours Program Description A glaucoma is a heterogeneous group of diseases that has become a significant cause of irreversible blindness worldwide. A glaucoma group of optic neuropathies…
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | 1.50 Credits Webcast Time to Complete: 90 minutes Released: February 16, 2024 Expires: February 16, 2025 Maximum Credits: 1.50 / AMA PRA Category 1 CreditsTM Program Description This webcast provides an update on the blood-based markers (BBMs) improve randomized clinical trials (RCTs) design and conduct of Alzheimer’s disease. It remains to be determined if the data available…
Sustained-Release Drug Delivery System in the Management of Glaucoma

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | CNE 1.25 Credits Webcast Time to Complete: 75 minutes Released: March 15, 2023 Expires: March 15, 2024 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM 1.25 / ANCC Contact Hours Program Description A glaucoma is a heterogeneous group of diseases that has become a significant cause of irreversible blindness worldwide. A glaucoma group of optic neuropathies…
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases

June 20, 2025 @ 8:00 AM - 5:00 PM

CME | CNE 1.25 Credits Webcast Time to Complete: 1.25 hours Released: December 14, 2022 Expires: December 14, 2023 Maximum Credits: 1.25 / AMA PRA Category 1 CreditsTM 1.25 / ANCC Contact Hours Program Description Inflammatory bowel diseases (IBD), commonly categorized as Crohn’s disease (CD) and ulcerative colitis (UC), are immune mediated chronic inflammatory disorders of the gastrointestinal tract.…
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis

June 20, 2025 @ 8:00 AM - 5:00 PM

March 1, 2025 Take Me to the Event Registration EVENT Summary Dates Saturday, March 1, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT Location…
July 2025
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN

July 19, 2025 @ 8:00 AM - 5:00 PM

July 19, 2025 Take Me to the Event Registration EVENT Summary Dates Saturday, July 19, 2025, 10:00 AM ET, 9:00 AM CT, 8:00 AM MT, and 7:00 AM PT Location Virtual Target Audience Cardiologists, neurologists, geneticists, radiologists, primary care physicians, nurse practitioners, physician assistants, and nurses who diagnose and treat patients with hereditary transthyretin amyloidosis…
November 2025
Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery

Featured November 15, 2025 @ 8:25 AM - 12:30 PM

Zoom Live Webinar , United States

Hybrid Event

June 2025

MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes

Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options

New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease

Sustained-Release Drug Delivery System in the Management of Glaucoma

New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases

Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis

July 2025

New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN

November 2025

Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery

Site Links

Quick Links

Categories